Related Experiment Video
Updated: Oct 18, 2025
07:50
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
4.7K
Tackling Ischemic Reperfusion Injury With the Aid of Stem Cells and Tissue Engineering
Mauricio Zamorano1, Rodrigo L Castillo2, Jorge F Beltran1
1Department of Chemical Engineering, Universidad de La Frontera, Temuco, Chile.
Frontiers in Physiology
|October 4, 2021
Summary
Tissue engineering offers promising therapies for ischemia-reperfusion injury (IRI) by using stem cells, growth factors, and biomaterials. This approach aims to salvage tissues and develop better treatments for conditions like stroke and heart attack.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Cellular Biology
Background:
- Ischemia reduces oxygen supply to tissues, often due to blockages.
- Reperfusion, while necessary, can cause significant damage through inflammation and oxidative stress.
- Ischemia-reperfusion injury (IRI) contributes to various organ failures, chronic wounds, and mortality.
Purpose of the Study:
- To review tissue engineering strategies for treating ischemia-reperfusion injuries (IRIs).
- To highlight the potential of cell therapeutics and tissue-mimetics in addressing IRI.
- To bridge the gap between preclinical research and clinical applications for IRI.
Main Methods:
- Utilizing stem cells for their self-renewal, differentiation, and anti-inflammatory properties.
- Employing growth factors to stimulate cell growth and tissue development.
- Integrating functional biomaterials to create microarchitectures for cell interaction.
- Applying bioprocess design to mimic the in vivo tissue environment.
Main Results:
- Tissue engineering enables the production of cell therapeutics to combat IRI.
- Development of physiological-tissue-mimetics for studying IRI and drug assessment.
- Potential for improved understanding and treatment of conditions like stroke, myocardial infarction, and organ damage.
Conclusions:
- Tissue engineering presents a versatile platform for tackling IRI.
- This approach holds promise for developing novel preventive and palliative therapies.
- Advancing tissue engineering applications can accelerate clinical translation for IRI treatments.
